• NIRAJ CHOUREY Department of , Babina, Uttar Pradesh, India.
  • HIREMATH RN Department of Bengaluru, Karnataka, India.
  • MANPAL SINGH YADAV Department of Babina, Uttar Pradesh, India.
  • SHARVAN DOBI Department of Delhi,


One of the risk factors for maternal mortality is morbidly adherent placenta (MAP) and accounts for 7–10% of maternal mortality cases worldwide. Placenta accreta is the most common type of MAP, while the other two types are placenta increta and placenta percreta. Placenta accrete accounts for 75–80% of MAP. Here, we present a case of 22 years old, primigravida with no known antenatal risk factors, diagnosed to have placenta accreta intraoperatively after delivering health baby. It is extremely rare for MAP to occur in a patient with no prior risk factors in a primigravida. Peripartum hysterectomy is the only option in a limited care facility with a hemodynamically unstable patient without a proper full-fledged blood bank facility. It is once again reiterated that bleeding from the vagina that does not slow or stop, drop in blood pressure and signs of shock are early signs of blood loss and should be investigated with great concern.

Keywords: Placenta Accreta, Primigravida, Morbidly adherent placenta


1. Fujisaki M, Furukawa S, Maki Y, Oohashi M, Doi K, Sameshima H. Maternal morbidity in women with placenta previa managed with prediction of morbidly adherent placenta by ultrasonography. J Pregnancy 2017;2017:8318751.
2. Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, Hsieh TT. Risk factors for placenta accrete. Obstet Gynecol 1999;93:545-50.
3. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-61.
4. Jacques SM, Qureshi F, Trent VS, Ramirez NC. Placenta accreta mild cases diagnosed by placental examination. Int J Gynecol Pathol 1996;15:28-33.
5. Chandraharan E, Rao S, Belli AM, Arulkumaran S. The triple-P procedure as a conservative surgical alternative to peripartum hysterectomy for placenta percreta. Int J Gynaecol Obstet 2012;117:191-4.
6. Konijeti R, Rajfer J, Askari A. Placenta percreta and the urologist. Rev Urol 2009;11:173-6.
7. Styron AG, George RB, Allen TK, Peterson-Layne C, Muir HA. Multidisciplinary management of placenta percreta complicated by embolic phenomena. Int J Obstet Anesth 2008;17:262-6.
8. Mathelier AC, Karachorlu K. Placenta previa and accreta complicated by amniotic fluid embolism. Int J Fertil Womens Med 2006;51:28-32.
9. Washecka R, Behling A. Urologic complications of placenta percreta invading the urinary bladder: A case report and review of the literature. Hawaii Med J 2002;61:66-9.
10. O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: Conservative and operative strategies. Am J Obstet Gynecol 1996;175:1632-8.
11. Sheikh SM, Khair H. Conservative management of placenta accrete. Isra Med J 2012;4:35-8.
12. Shander A, Goodnough LT. Update on transfusion medicine. Pharmacotherapy 2007;27:57S-68.
13. Committee on Obstetric Practice. ACOG committee opinion. Placenta accreta. Number 266, January 2002. American college of obstetricians and gynecologists. Int J Gynaecol Obstet 2002;77:77-8.
14. Comstock CH, Love JJ Jr., Bronsteen RA, Lee W, Vettraino IM, Huang RR, et al. Sonographic detection of placenta accreta in the second and third trimesters of pregnancy. Am J Obstet Gynecol 2004;190:1135-40.
15. Shamshirsaz AA, Fox KA, Salmanian B, Diaz-Arrastia CR, Lee W, Baker BW, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol 2015;212:218.e1-9.
16. Tikkanen M, Paavonen J, Loukovaara M, Stefanovic V. Antenatal diagnosis of placenta accreta leads to reduced blood loss. Acta Obstet Gynecol Scand 2011;90:1140-6.
17. Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 2010;115:65-9.
18. Eller AG, Porter TT, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009;116:648-54.
19. Bailit JL, Grobman WA, Rice MM, Reddy UM, Wapner RJ, Varner MW, et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol 2015;125:683-9.
20. Hall T, Wax JR, Lucas FL, Cartin A, Jones M, Pinette MG. Prenatal sonographic diagnosis of placenta accrete-impact on maternal and neonatal outcomes. J Clin Ultrasound 2014;42:449-55.
21. Kuhite H, Mirji S, Shingatgeri S, Shinde G. A rare case of morbidly adherent placenta in a primigravida. World J Anemia 2018;2:74-7.
22. Arnadottir BT, Hardardóttir H, Marvinsdóttir B. Case report seventeen year old primipara with placenta increta treated with methotrexate. Laeknabladid 2008;94:549-52.
23. Ramalingam, Sahika G. A rare placental abnormality in primigravida. Indian J Res 2019;8:562-6.
24. Kinoshita T, Ogawa K, Yasumizu T, Kato J. Spontaneous rupture of the uterus due to placenta percreta at 25-weeks of gestation: A case report. J Obstet Gynaecol Res 1996;22:125-8.
25. Rajkumar B, Kumar N, Sowmya S. Placenta percreta in primigravida, an unsuspected situation. Int J Reprod Contracep Obstet Gynecol 2014;3:239-41.
26. Fox H. Placenta accreta 1945-1969. Obstet Gynecol Surv 1972;27:475-9.
10 Views | 20 Downloads
How to Cite
CHOUREY, N., H. RN, M. S. YADAV, and S. DOBI. “PLACENTA ACCRETA IN PRIMIGRAVIDA AT PERIPHERAL SETUP – A RARE CASE REPORT”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 14, no. 6, June 2021, pp. 3-5, doi:10.22159/ajpcr.2021.v14i6.42115.
Case Study(s)